D-Wave's Quantum Gamble: $100M Government Funding and Record Bookings, But Where's the Revenue?
23.05.2026 - 21:52:08 | boerse-global.de
The contrast in D-Wave Quantum's latest chapter could hardly be starker. On one side, a $100 million letter of intent from the US Commerce Department under the CHIPS and Science Act — part of a $2.013 billion program to turbocharge domestic quantum computing. On the other, a first-quarter revenue figure that collapsed 80.9% year-over-year to just $2.86 million, undershooting the $4.19 million analysts had penciled in.
The market, however, chose to cheer the government backing. Shares closed Friday at €25.04 in European trading, a one-day pop of 13.1% and a weekly surge of 42.96%. The stock now sits roughly 57% above its 50-day moving average of €15.98, though it remains almost 35% shy of its 52-week high of €38.48. The entire quantum sector caught a tailwind: Rigetti Computing climbed 19.87%, IBM added 12.43%, and even IonQ — which didn't receive direct funding — rose 7.87%.
Digging into the numbers, the real story lies in the yawning gap between bookings and recognized revenue. Bookings exploded to a record $33.4 million in the quarter, a staggering 2,000% increase. Buried in that figure is a $20 million system sale to Florida Atlantic University for an Advantage2 quantum computer. CEO Alan Baratz called the government nod a "transformative moment," and the pipeline clearly points to future revenue. Yet the income statement tells a humbler tale: the loss per share came in at $0.05, better than the $0.08 the Street expected, but the top line continues to shrink as large one-off system sales from the prior year distort comparisons.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The company plans to funnel the CHIPS money into its existing quantum-annealing systems and next-generation gate-model machines, with new R&D centers slated for Boca Raton, Florida; New Haven, Connecticut; and Burnaby, Canada. D-Wave also recently acquired Quantum Circuits, positioning itself as a dual-platform player in the quantum space. With $588 million in cash and marketable securities and a gross margin around 83%, the balance sheet provides ample runway. But the annualized volatility of 148% underscores just how speculative the equity has become.
Analyst sentiment is broadly constructive. Fourteen analysts recommend buying, two say hold, and one says sell. The average price target sits at $34.67, with Rosenblatt the most bullish at $43. TD Cowen tagged D-Wave as one of the biggest beneficiaries of the federal quantum program. Institutional buyers including Leonteq Securities and Banque Cantonale Vaudoise have recently added to positions. But the technical picture gives pause: the relative strength index of 47 signals neutral territory, and with the stock having rallied so sharply, some exhaustion may be setting in.
Insider activity adds another layer of nuance. Vice President Sophie C. Ames sold 23,025 shares on May 20 at $18.98 as part of a planned transaction, while CFO J. Markovich exited a stake in March at $17.63. Meanwhile, short interest has climbed to 14.1% of the float, near its historical peak — a dynamic that likely fueled the recent volatility as short sellers scrambled to cover. The question now is whether the bookings explosion can translate into sustained revenue before the market's patience with a near-$11 billion valuation wears thin. For D-Wave, the government lifeline has bought time, but the execution clock is ticking.
Ad
D-Wave Quantum Stock: New Analysis - 23 May
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
